Maryland SB495 mandates the screening of newborn infants for Gaucher disease.
Maryland SB495 requires the Department of Health to screen all newborn infants for Gaucher disease. The bill mandates the Department to establish a coordinated statewide system for screening hereditary and congenital disorders. It also requires the Department to implement testing for core conditions within a specified timeframe after they are added to the U.S. Department of Health and Human Services’ Recommended Uniform Screening Panel. The bill includes provisions for reporting, follow-up, and treatment activities with parents, caregivers, and health care providers.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.